Large-cap stocks in software, electric vehicles, data centers, and healthcare faced significant pressure last week due to weak guidance, regulatory concerns, rising bond yields, and competitive risks. Technology and China-linked companies led the declines, with ten major stocks experiencing notable losses ranging from 4.96% to 18.28%.

Tenet Healthcare reported mixed Q1 2026 results with adjusted EPS of $4.82 beating consensus of $4.18, but sales of $5.37B missed expectations of $5.39B. The company blamed unfavorable payer mix from lower exchange admissions and winter storms for soft performance. Despite this, Tenet raised full-year adjusted earnings guidance to $16.38-$18.68 per share and reaffirmed sales guidance of $21.5-$22.3B. The stock declined 5.95% on the news.

Tenet Healthcare reported strong Q4 2025 results with sales of $5.527 billion (up 8.9% YoY) and adjusted EPS of $4.70 (up from $3.44), beating consensus estimates. The company saw growth across both hospital operations and ambulatory segments, driven by higher acuity cases and favorable payer mix. For 2026, Tenet expects revenue guidance of $21.5-$22.3 billion and adjusted EBITDA of $4.485-$4.785 billion, with shares rising 6.73% on the news.

Tenet Healthcare demonstrates strong financial performance with impressive Q2 2025 results, featuring revenue growth, margin expansion, and strategic focus on ambulatory care. The company shows potential for growth despite potential future Medicaid policy challenges.

Tenet Healthcare reported strong Q2 2025 earnings, with adjusted EPS of $4.02, exceeding analyst expectations. The company saw revenue growth in Ambulatory Care and raised its full-year financial guidance, driven by margin improvements and strategic portfolio shifts.

Several large-cap companies, including Duolingo, CoreWeave, and DexCom, saw significant gains last week due to strong earnings, sales guidance, and analyst upgrades.

The global plastic fencing market is expected to grow significantly due to rising demand from the residential and commercial construction industries, as well as the increasing adoption of recycled plastics in fencing products.

Tenax Therapeutics, a Phase 3 pharmaceutical company, announced its participation in the Guggenheim SMID Cap Biotech Conference, where its President and CEO will present in a fireside chat.

The White House has ordered a temporary freeze on all federal grants and loans, putting $3 trillion in funding under scrutiny and threatening industries like clean energy, defense, and healthcare.

The article discusses the evolving landscape of rare cardiovascular diseases, including Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy. It highlights the challenges in diagnosis and treatment, as well as the growing market size and pipeline of new therapies for these conditions.

The behavioral rehabilitation market is expected to grow rapidly, driven by increasing mental health awareness and the rising global addiction crisis. The substance abuse disorder segment dominates the market, with a focus on personalized treatments and innovations in telemedicine. North America leads the market due to high awareness of dementia and a strong healthcare system.

The Ensign Group has acquired the operations of a nursing facility in Kansas and seven nursing facilities in Colorado, expanding its footprint in these states. The acquisitions are expected to increase the company's revenues and profits.